Hepatitis B and C Within the Chinese Community in Milan
NCT ID: NCT07241962
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
1000 participants
OBSERVATIONAL
2025-12-31
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Does community-based, culturally sensitive screening increase the detection of undiagnosed HBV and HCV infections in this high-risk population?
* What is the level of adherence, satisfaction and awareness regarding rapid testing methods in this community?
Participants will:
* Receive pre-test counseling in Italian or Chinese with the help of an interpreter
* Complete a brief, anonymous questionnaire on demographics, risk factors and awareness of HBV/HCV
* Undergo capillary rapid testing for HBV and/or HCV
* Receive test results during the same visit
* Complete a short post-test satisfaction questionnaire
The study will be conducted in public spaces within Milan's Chinatown, during monthly sessions, until 1,000 participants are enrolled. Each session will last approximately 30-60 minutes per participant.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.
NCT05813691
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
NCT03097952
Observational Study on Patients With Chronic Hepatitis B
NCT02167503
A Comprehensive HBsAg-positive Patients Centered Screening Strategy
NCT03794791
Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination
NCT05523921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identified as part of the Chinese community residing in Milan
* Willing and able to provide informed consent
* Willing to undergo HBV and/or HCV rapid screening (capillary blood test)
* Able to complete an anonymous questionnaire on demographics, risk factors and awareness of HBV and HCV infections
* Able to communicate in Italian or Chinese (with interpreter assistance, if needed)
Exclusion Criteria
* Not from the Chinese community or not residing in Milan
* Unable to provide informed consent
* Currently undergoing treatment for HBV or HCV, or with previously confirmed diagnosis of HBV or HCV
* Severe mental or physical illness impairing participation or understanding of consent
* Unable to respond to the questionnaire, even with interpreter assistance
* Pregnant women
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS Ospedale San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Federica Invernizzi
Doctor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OBS-CHN-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.